Companies/ImmuneBiotech Medical Sweden AB
Follow

ImmuneBiotech Medical Sweden AB

Nasdaq First North GM (Sweden)

ImmuneBiotech discovers and develops novel probiotics for therapeutic effect based on lactic acid bacteria and symbiotic formulations targeting gut microbiota and the immune system. We deliver transformational solutions to modulate the microbiome, heal leaky gut and reduce inflammation to prevent and treat autoimmune and other chronic inflammatory conditions.

Sector:
HEALTH CARE
 
Top
News
No available news yet for ImmuneBiotech Medical Sweden AB
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in ImmuneBiotech Medical Sweden AB with ticker
Status
Inactive
Amount of instruments
—
Currency
SEK
Type
Price
Pre-money
Time
Files
Listing
2022
Direct listing of ImmuneBiotech Medical Sweden AB on Nasdaq First North GM

We have reserved some of the more detailed information for our registered users. Please sign in if You have already registered.

Get access to Events, Instruments, Documents, Media and much more by signing up for FREE!

Partially obscured image showing event data
Sign up for FREE
People
Shahram Lavasani
CEO
Mehrnaz Nouri
Board member
Derek Batcheller
Board member
Shahram Lavasani
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Scheelevägen 2
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556939-2813
LEI code
First trade date
Registration date
15 Aug 2013
Short name
ImmuneBiotech

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More